Sr. Manager/Associate Director, Market Access Marketing (Calcilytix) jobs in United States
cer-icon
Apply on Employer Site
company-logo

BridgeBio · 4 hours ago

Sr. Manager/Associate Director, Market Access Marketing (Calcilytix)

BridgeBio is a pioneering biotech company focused on developing life-changing medicines for patients with unmet needs. They are seeking a Sr. Manager/Associate Director, Market Access Marketing to support the execution of Market Access strategies, manage marketing materials, and collaborate with various stakeholders in a fast-paced environment.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Serve as the market access marketing lead responsible for all Market Access marketing tactics, including but not limited to: payer value proposition, payer communications, patient services, field reimbursement support, trade and distribution, and pricing and reimbursement support
Oversee and manage day-to-day activities with market access marketing agencies; manage and monitor market access marketing materials budget and vendor contracts
Develop and review key market access marketing materials and lead projects through the medical, legal, and regulatory (MLR) or promotional review committee (PRC) review and approval process
Support launch readiness through leading Market Access planning meetings and participating in brand planning and other internal meetings
Collaborate with training to ensure effective, impactful, best in class training for Market Access field teams
Act as a subject matter expert on market access trends and implications for strategic planning; research competitive market access pieces and payer initiatives and keep the organization well informed of external initiatives and impact

Qualification

Market Access MarketingBiotech/Pharma experienceProject ManagementPayer CommunicationsPricingContractingAnalytical SkillsLeadershipStrategic ThinkingCommunication Skills

Required

BA/BS degree required
Minimum of 8+ years of Biotech/Pharma experience
Track record of successful launch execution in Market Access, preferably in rare diseases or specialty therapeutics
Excellent communication, leadership, analytical and strategic-thinking skills
Ability to work under pressure and to manage and execute multiple projects simultaneously
Strong project management skills and attention to detail
15 - 25% Travel

Preferred

MBA preferred

Benefits

401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

Company

BridgeBio

twittertwittertwitter
company-logo
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Funding

Current Stage
Public Company
Total Funding
$4.9B
Key Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Post Ipo Debt· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M

Leadership Team

leader-logo
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
linkedin
leader-logo
Neil Kumar
CEO and Founder
linkedin
Company data provided by crunchbase